{"nct_id":"NCT02454270","title":"A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies","status":"TERMINATED","status_verified_date":"2018-12","start_date":"2015-06-15","start_date_type":"ACTUAL","primary_completion_date":"2018-07-26","primary_completion_date_type":"ACTUAL","completion_date":"2018-07-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}